ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Boehringer Ingelheim India to sustain growth momentum in 2021, focuses on partnerships in NCD management
March 26, 2021In addition to Human Pharma, Boehringer Ingelheim India’s Animal Health business, which focuses on advanced, preventive health solutions for Pets and Poultry, aims to more than double the sales over the coming five years. -
Alembic Pharma raises Rs 150 crore via NCDs
March 20, 2019Drug firm Alembic Pharmaceuticals has said it has raised Rs 150 crore through the allotment of non-convertible debentures (NCDs) on private placement basis. These NCDs carry a coupon rate of 8.37 per cent per annum and are proposed to be listed on NSE. -
NCD poses major challenge for Asia-Pacific
October 13, 2017While NCDs pose a global challenge, it is imperative to highlight that developing countries – whose healthcare systems are already under stress
Pharma Sources Insight January 2025
